Boston Scientific Corporation vs Mercadolibre Inc — how do they compare? Boston Scientific Corporation trades at $51.17 (market cap $74.19B), while Mercadolibre Inc trades at $1,930 (market cap $98.35B). The key difference: Mercadolibre Inc is the larger of the two by market cap, and Mercadolibre Inc is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | MELI | |
|---|---|---|
Market Cap | $74.19B | $98.35B |
Sector | Health | Consumer Cyclical |
52-Week High | $108.14 | $2.51K |
52-Week Low | $42.63 | $1.55K |
Enterprise Value | $86.27B | $106.00B |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →